| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| nipocalimab phase 2 results | 0.74 | 0.4 | 2528 | 58 | 27 |
| nipocalimab | 1.02 | 0.2 | 5436 | 7 | 11 |
| phase | 0.98 | 0.8 | 8009 | 98 | 5 |
| 2 | 1.96 | 1 | 8285 | 47 | 1 |
| results | 1.57 | 1 | 1262 | 84 | 7 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| nipocalimab phase 3 results | 1.62 | 0.7 | 3793 | 98 |
| nipocalimab mechanism of action | 0.5 | 0.4 | 9889 | 20 |
| pdufa date for nipocalimab | 1.13 | 0.4 | 4108 | 43 |
| nip adalimumab mechanism of action | 1.09 | 0.3 | 1554 | 31 |
| ipilimumab and nivolumab mechanism of action | 0.58 | 0.8 | 581 | 17 |
| mechanism of action of nivolumab | 0.71 | 0.8 | 8327 | 68 |
| caplacizumab mechanism of action | 1.15 | 0.8 | 8880 | 61 |
| capmatinib mechanism of action | 0.19 | 0.7 | 2372 | 84 |
| niraparib mechanism of action | 1.49 | 0.8 | 3209 | 35 |
| pozelimab mechanism of action | 1.81 | 0.2 | 2900 | 36 |
